Steven Crossley, Head of Strategy for GENETWORx, said that a team of acquisition specialists will perform outreach to multiple prospects from diverse sectors of the industry including academic institutions, operating laboratory companies, innovators and inventors, divisions of large companies, and private equity firms. GENETWORx is looking to expand its molecular testing expertise in early cancer detection, Next Generation Sequencing (NGS), genetic testing, Pharmacogenetics (PGx), and new and innovative molecular diagnostics for both healthcare provider and consumer use. GENETWORx combines advancements in molecular and other diagnostics into actionable and patient-centered information to help physicians determine the most appropriate treatment regimen for each patient. GENETWORx, a national diagnostics and healthcare management services company
0 kommentar(er)
